These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17956151)

  • 1. The effectiveness criterion: balancing efficacy against the risks of weight gain.
    Citrome L
    J Clin Psychiatry; 2007; 68 Suppl 12():12-7. PubMed ID: 17956151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of olanzapine use in adolescents.
    Schulz C; Haight RJ
    Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study.
    Treuer T; Hoffmann VP; Chen AK; Irimia V; Ocampo M; Wang G; Singh P; Holt S
    World J Biol Psychiatry; 2009; 10(4 Pt 3):729-40. PubMed ID: 19606406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.
    Corrao MM; Nelson LA
    CNS Drugs; 2022 Jun; 36(6):605-616. PubMed ID: 35644903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine: a 5-year perspective.
    Littrell KH; Petty RG; Wolf NM
    Expert Rev Neurother; 2006 Jun; 6(6):811-21. PubMed ID: 16784405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
    McClellan JM
    Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
    [No Abstract]   [Full Text] [Related]  

  • 9. Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder.
    Gao K; Fang F; Wang Z; Calabrese JR
    J Clin Psychopharmacol; 2016 Dec; 36(6):637-642. PubMed ID: 27753728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study.
    Milano W; Grillo F; Del Mastro A; De Rosa M; Sanseverino B; Petrella C; Capasso A
    Adv Ther; 2007; 24(1):123-34. PubMed ID: 17526469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental antipsychotics and metabolic adverse effects--findings from clinical trials.
    Tschoner A; Fleischhacker WW; Ebenbichler CF
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1041-8. PubMed ID: 19777392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Olanzapine].
    Nagai N; Watanabe K
    Nihon Rinsho; 2013 Apr; 71(4):666-72. PubMed ID: 23678597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
    Strassnig M; Miewald J; Keshavan M; Ganguli R
    Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?
    Faden J; Serdenes R; Citrome L
    Expert Rev Neurother; 2022 May; 22(5):365-376. PubMed ID: 35354374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.